Plain-English translation of NCT05024734 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to treating intermediate-risk non-muscle invasive bladder cancer. Instead of giving all patients the same medication, doctors will grow a small sample of your tumor in the lab and test it against four different drugs (, , , and ) to see which one works best for your cancer. You'll then receive the medication that performed best in your personal tumor test.
Currently, doctors choose bladder cancer medications based on general guidelines rather than what will work best for each individual patient. This trial aims to personalize treatment by using lab testing to match patients with the medication most likely to be effective for their specific tumor.
You likely qualify if…
You likely don't qualify if…
During your bladder surgery, doctors will collect a tumor sample and grow it as a mini-model in the lab for about 10 days. They'll then test this model against four different medications to see which one kills your cancer cells most effectively. Once the best medication is identified, you'll receive weekly treatments directly into your bladder for 6 weeks, then be followed according to standard cancer care.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Switzerland